Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.882
-0.039 (-4.22%)
Feb 21, 2025, 4:00 PM EST - Market closed
Biodesix Employees
Biodesix had 217 employees as of December 31, 2023. The number of employees decreased by 28 or -11.43% compared to the previous year.
Employees
217
Change (1Y)
-28
Growth (1Y)
-11.43%
Revenue / Employee
$302,129
Profits / Employee
-$201,931
Market Cap
128.30M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 217 | -28 | -11.43% |
| Dec 31, 2022 | 245 | 27 | 12.39% |
| Dec 31, 2021 | 218 | 18 | 9.00% |
| Dec 31, 2020 | 200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
BDSX News
- 4 days ago - Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - GlobeNewsWire
- 6 weeks ago - Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited) - GlobeNewsWire
- 6 weeks ago - Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study - GlobeNewsWire
- 4 months ago - Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Biodesix Announces Third Quarter 2024 Results and Highlights - GlobeNewsWire
- 4 months ago - Biodesix to Participate in Three Investor Conferences in November - GlobeNewsWire
- 4 months ago - Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024 - Business Wire
- 4 months ago - Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study - Business Wire